<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>sigtran2000</title><link>https://investorshangout.com/profile/view?id=68497</link><description><![CDATA[sigtran2000]]></description><language>en-us</language><pubDate>Tue, 22 Sep 2026 08:40:11 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/profile/view?id=68497" rel="self" type="application/rss+xml"/><item><title>sigtran2000: Thanks for the summary gestalt. I total agree</title><link>https://investorshangout.com/post/view?id=6685976</link><guid>https://investorshangout.com/post/view?id=6685976</guid><description><![CDATA[sigtran2000
]]></description><pubDate>Thu, 18 Apr 2024 16:39:37 GMT</pubDate></item><item><title>sigtran2000: I don’t think this is the only thing behind the</title><link>https://investorshangout.com/post/view?id=6346702</link><guid>https://investorshangout.com/post/view?id=6346702</guid><description><![CDATA[sigtran2000
]]></description><pubDate>Thu, 17 Feb 2022 23:50:09 GMT</pubDate></item><item><title>sigtran2000: Poor design trial and lacking of both human and</title><link>https://investorshangout.com/post/view?id=6342389</link><guid>https://investorshangout.com/post/view?id=6342389</guid><description><![CDATA[sigtran2000
]]></description><pubDate>Sat, 12 Feb 2022 03:53:57 GMT</pubDate></item></channel></rss>